The global cancer biopsy market size was valued at USD 30.96 billion in 2024 and is estimated to reach from USD 33.38 billion ...
Thanks to advancements in medical technology. The global biopsy devices market is projected to rise to $4.02b by 2033 at a ...
Key updates from SABCS 2024 in early breast cancer include the COMET study on DCIS recurrence, INSEMA trial on SLNB omission, and OlympiA updates on adjuvant olaparib, shared by Dr Harold Burstein.
The choice between a core needle biopsy and a vacuum-assisted biopsy depends on factors such as the size and location of the ...